Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers

被引：0
|
作者：
Guillaume Beinse
Pierre-Alexandre Just
Marie-Aude Le Frere Belda
Pierre Laurent-Puig
Sebastien Jacques
Meriem Koual
Simon Garinet
Karen Leroy
Nicolas Delanoy
Helene Blons
Claire Gervais
Catherine Durdux
Charles Chapron
François Goldwasser
Benoit Terris
Cecile Badoual
Valerie Taly
Anne-Sophie Bats
Bruno Borghese
Jérôme Alexandre
机构：
[1] Sorbonne Université,Centre de Recherche des Cordeliers, « Equipe labélisée Ligue Contre le Cancer », CNRS SNC 5096
[2] Université de Paris Cité,Institut du Cancer Paris CARPEM, AP
[3] INSERM,HP, APHP.Centre, Department of Medical Oncology
[4] Hopital Cochin,Institut du Cancer Paris CARPEM, AP
[5] Hopital Cochin,HP, APHP.Centre, Department of Pathology
[6] Université de Paris Cité,Institut du Cancer Paris CARPEM, AP
[7] Hopital Européen Georges Pompidou,HP, APHP.Centre, Department of Pathology
[8] Hopital Européen Georges Pompidou,Institut du Cancer Paris CARPEM, AP
[9] Institut du Cancer Paris CARPEM,HP, APHP.Centre, Department of Biology
[10] AP-HP,Institut du Cancer Paris CARPEM, AP
[11] APHP.Centre,HP, APHP.Centre, Department of Gynecological Surgery
[12] GENOM’IC platform,Institut du Cancer Paris CARPEM, AP
[13] Institut Cochin,HP, APHP.Centre, Department of Medical Oncology
[14] Hopital Européen Georges Pompidou,Institut du Cancer Paris CARPEM, AP
[15] Hopital Européen Georges Pompidou,HP, APHP.Centre, Department of Radiotherapy
[16] Hopital Européen Georges Pompidou,Institut du Cancer Paris CARPEM, AP
[17] Hopital Cochin,HP, APHP.Centre, Department of Gynecological Surgery
来源：
British Journal of Cancer | 2022年 / 127卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1123 / 1132
页数：9
相关论文
共 45 条
  • [1] Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers
    Beinse, Guillaume
    Just, Pierre-Alexandre
    Le Frere Belda, Marie-Aude
    Laurent-Puig, Pierre
    Jacques, Sebastien
    Koual, Meriem
    Garinet, Simon
    Leroy, Karen
    Delanoy, Nicolas
    Blons, Helene
    Gervais, Claire
    Durdux, Catherine
    Chapron, Charles
    Goldwasser, Francois
    Terris, Benoit
    Badoual, Cecile
    Taly, Valerie
    Bats, Anne-Sophie
    Borghese, Bruno
    Alexandre, Jerome
    BRITISH JOURNAL OF CANCER, 2022, 127 (06) : 1123 - 1132
  • [2] Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival
    Mukhopadhyay, Asima
    Plummer, Elizabeth R.
    Elattar, Ahmed
    Soohoo, San
    Uzir, Bisha
    Quinn, Jennifer E.
    McCluggage, W. Glenn
    Maxwell, Perry
    Aneke, Harriet
    Curtin, Nicola J.
    Edmondson, Richard J.
    CANCER RESEARCH, 2012, 72 (22) : 5675 - 5682
  • [3] Endogenous base damage as a driver of genomic instability in homologous recombination-deficient cancers
    Aubuchon, Lindsey N.
    Verma, Priyanka
    DNA REPAIR, 2024, 141
  • [4] Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers
    Janysek, Dawn C.
    Kim, Jennifer
    Duijf, Pascal H. G.
    Dray, Eloise
    TRANSLATIONAL ONCOLOGY, 2021, 14 (03):
  • [5] Precision targeting of Homologous Recombination-deficient cancers using microRNA synthetic lethality
    Srinivasan, Gayathri
    Williamson, Elizabeth
    Hromas, Robert
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
  • [6] Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC
    Seiichi Imanishi
    Yasuto Naoi
    Kenzo Shimazu
    Masafumi Shimoda
    Naofumi Kagara
    Tomonori Tanei
    Tomohiro Miyake
    Seung Jin Kim
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2019, 174 : 627 - 637
  • [7] The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas
    van Wijk, Lise M.
    Vermeulen, Sylvia
    Meijers, Matty
    van Diest, Manuela F.
    ter Haar, Natalja T.
    de Jonge, Marthe M.
    Solleveld-Westerink, Nienke
    van Wezel, Tom
    van Gent, Dik C.
    Kroep, Judith R.
    Bosse, Tjalling
    Gaarenstroom, Katja N.
    Vrieling, Harry
    Vreeswijk, Maaike P. G.
    CANCERS, 2020, 12 (10) : 1 - 16
  • [8] Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC
    Imanishi, Seiichi
    Naoi, Yasuto
    Shimazu, Kenzo
    Shimoda, Masafumi
    Kagara, Naofumi
    Tanei, Tomonori
    Miyake, Tomohiro
    Kim, Seung Jin
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (03) : 627 - 637
  • [9] RNA-mediated DNA repair: A novel repair pathway in homologous recombination-deficient cancers.
    Jalan, Manisha
    Patel, Juber
    Olsen, Kyrie S.
    Ahmed-Seghir, Sana
    Higginson, Daniel S.
    Reis-Filho, Jorge S.
    Riaz, Nadeem
    Powell, Simon N.
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination
    Setton, Jeremy
    Selenica, Pier
    Mukherjee, Semanti
    Shah, Rachna
    Pecorari, Isabella
    McMillan, Biko
    Pei, Isaac X.
    Kemel, Yelena
    Ceyhan-Birsoy, Ozge
    Sheehan, Margaret
    Tkachuk, Kaitlyn
    Brown, David N.
    Zhang, Liying
    Cadoo, Karen
    Powell, Simon
    Weigelt, Britta
    Robson, Mark
    Riaz, Nadeem
    Offit, Kenneth
    Reis-Filho, Jorge S.
    Mandelker, Diana
    NPJ BREAST CANCER, 2021, 7 (01)
12345